Z ika virus belongs to the family Flaviviridae (see Supplementary Notes) and is an emerging mosquito-transmitted human pathogen of considerable medical importance 6, 7 , due to its association with a range of primarily neurological congenital abnormalities now termed congenital Zika syndrome 8 . The viral determinants required for replication in different host environments are under strong purifying selection during natural virus evolution, making it challenging to identify the determinants that are necessary for viral fitness in different hosts. DMS of viral proteins is emerging as a powerful tool to address this issue, allowing identification of amino acid residues that are optimal for viral replication in specific selective environments in a matter of days [2] [3] [4] [5] 9, 10 . DMS involves generation of libraries containing all codon substitutions of a viral protein, selecting these libraries in different host environments and employing deep sequencing and computational analyses to identify substitutions that are selected in the specific host environments. Herein we applied DMS to the ZIKV envelope protein E with the aim of identifying amino acids beneficial for virus replication in mammalian or mosquito host cells.
. The viral determinants required for replication in different host environments are under strong purifying selection during natural virus evolution, making it challenging to identify the determinants that are necessary for viral fitness in different hosts. DMS of viral proteins is emerging as a powerful tool to address this issue, allowing identification of amino acid residues that are optimal for viral replication in specific selective environments in a matter of days [2] [3] [4] [5] 9, 10 . DMS involves generation of libraries containing all codon substitutions of a viral protein, selecting these libraries in different host environments and employing deep sequencing and computational analyses to identify substitutions that are selected in the specific host environments. Herein we applied DMS to the ZIKV envelope protein E with the aim of identifying amino acids beneficial for virus replication in mammalian or mosquito host cells.
Results

DMS of C-terminal 204 residues of ZIKV envelope protein (E) and selection of beneficial mutations in mosquito and mammalian cells.
We performed DMS on the C-terminal 204 residues of ZIKV (Natal 2015 strain 11, 12 ) E protein, which encompasses the putative receptor-binding domain III (E-DIII) and the stem-anchor regions (E-TM1 and E-TM2). This region of E protein was selected because of its role in mediating receptor-dependent infection and to avoid the N-terminal part of the E protein, which contains an N-glycosylation site at position 154. Previous studies showed that ablation of glycosylation at this site improved ZIKV infection in mosquito cells 13, 14 . Table 1 ) encoding a central codon-targeted 'NNN' sequence (nucleobase = A/T/G/C), a complementary DNA (cDNA) amplicon library was generated (Fig. 1a ) in which each of the C-terminal 204 codons was designed to be substituted with all possible codon and amino acid variants (there are 204 × 63 = 12,852 possible single-codon substitutions, or 204 × 19 = 3,876 possible single-amino acid substitutions). To minimize sequencing errors, a barcoded subamplicon method [2] [3] [4] [5] was used (see Methods). Computational analysis of deep sequencing data using dms_tools2 (ref. 15 ; Supplementary Data 1, see also https://github.com/jbloomlab/ZIKV_DMS_w_Khromykh) identified 12,200 codon variants coding 3,827 amino acid variants in the amplicon library, representing 94.9 and 98.7% of all possible codon or amino acid variants, respectively (Fig. 1b,c) . Both synonymous and non-synonymous substitutions were present in the cDNA amplicon library, with non-synonymous mutations dominating ( Supplementary Fig. 1a ). More than 90% of possible Fig. 1b ). The amplicon library was included in a circular polymerase extension reaction (CPER) assembly with other ZIKV cDNA fragments to generate an infectious full-length ZIKV DMS cDNA library 12, [16] [17] [18] [19] [20] . This cDNA library was then transfected into Vero or C6/36 cells, and transfected cells were incubated for 8 (Vero) or 13 (C6/36) days to select for preferentially replicating viruses. Deep sequencing of recovered virus populations showed an expected purging of stop codons ( Supplementary Fig. 1a) , and identified three highly enriched substitutions in Vero cells (Q350L, T397S and a synonymous substitution ACA to AGG at position 416) and two highly enriched substitutions (K316Q and S461G) in C6/36 cells (Fig. 1d) . A synonymous substitution selected in mammalian cells is likely to have hitch-hiked with the other two non-synonymous beneficial substitutions. The strong selection of a small number of substitutions, along with a reduction in codon variants ( Supplementary Fig. 1b ), indicates a bottleneck, which appears to be stronger in Vero cells (mutation frequency of Q350L/T397S/ R416R approximately 0.95, and fewer low-frequency peaks) than in C6/36 cells (mutation frequency of K316Q/S461G approximately 0.8, and more lower-frequency peaks) ( Fig. 1d and Supplementary data 1 and 2). However, as our goal was not to systematically quantify the effects of all substitutions, but rather to select for specific host-adaptive substitutions, we proceeded with the analysis of enriched substitutions. Amplicons generated using forward (red arrows) and reverse (blue arrows) mutagenesis primers were combined with other ZIKV cDNA fragments to generate an infectious cDNA library by CPER. The CPER cDNA library was then transfected into mammalian (Vero) or mosquito (C6/36) cells; recovered viruses were harvested in culture supernatants, deep sequenced and analysed to identify preferentially selected viral mutants. dpt, days post-transfection. b, Graphical representation of deep sequencing data showing codon variant heatmap. c, Mutation frequency of cDNA amplicon library illustrating the extent of mutagenesis in the E-DIII stem-anchor region. Mutation frequency is defined as the percentage at which codon mutants are detected in sequenced molecules at each site. For example, at each site, if mutations are present in 100% of sequenced molecules, the frequency is 1; if not present in any sequenced molecules, the frequency is 0. d, Mutation frequency of cDNA library, mammalian (Vero) cell-selected virus population and mosquito (C6/36) cell-selected virus population. Identities of preferentially selected amino acid mutations are indicated above each peak.
Using DMS primers (Supplementary
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The deep sequencing data were also analysed for differential selection in mosquito compared to mammalian cells. The Supplementary Data 1 file contains a complete step-by-step data analysis of the DMS data using dms_tools2 (see also https://github. com/jbloomlab/ZIKV_DMS_w_Khromykh). For residues 316 and 461, a variety of amino acid variants were found in the mosquito cell-selected virus population, but in the mammalian cell-selected virus population only the wild type (WT) residues were found at these positions (K316 and S461, Supplementary data 1). For residues 350 and 397, a variety of amino acid variants were found in the mammalian cell-selected virus population but only the WT residues were found in the mosquito cell-selected virus population (Q350 and T397, Supplementary data 1). This reflects the flexibility that is allowed at these sites in a specific environment (for example, Vero cells), which is not allowed at the respective sites in the other environment (for example, C6/36 cells).
To examine whether viruses containing individual codon variants or viruses containing combinations of codon variants were selected in CPER cDNA-transfected cells, the virus populations selected in C6/36 or Vero cells were further passaged at low multiplicity of infection (MOI = 0.01) in C6/36 or Vero cells, respectively. The results showed that passaged viruses contained a combination of corresponding mutations-that is, C6/36 cell-selected virus contained a combination of two variants, 316Q and 461G-while Vero cell-selected virus contained combination of three variants, 350L, 397S and R416R ( Supplementary Fig. 2a ).
Validation of identified substitutions.
To further elucidate the roles of the aforementioned amino acid substitutions individually and in combination, individual mutant viruses 350L and 397S (mammalian-specific mutations), 316Q and 461 G (mosquitospecific mutations), as well as double mutants, 350L/397S and 316Q/461G, were generated. Immuno-plaque assay (iPA) in Vero cells showed that 350L, 397S and 350L/397S mutant viruses produced plaques similar in size to the WT virus, while 316Q, 461G, and 316Q/461G mutant viruses produced smaller plaques ( Fig. 2a and Supplementary Fig. 2b ).The mammalian-specific 350L/397S mutant virus grew to higher titres than WT virus in A549 (Fig. 2c) and IFNAR −/− MEF ( Supplementary Fig. 2c ), and replicated with efficiency similar to WT virus in both Vero cells (Fig. 2b ) and C6/36 cells (Fig. 2e) . Further analyses of RNA replication of mammalian-specific mutants in Vero cells by quantitative PCR with reverse transcription (RT-qPCR) revealed that only the double mutation 350L/397S provided considerable advantage in RNA replication ( Supplementary Fig. 2e ), indicating that selection in mammalian cells favours a virus with more efficiently replicating RNA.
The mosquito-specific 316Q/461G virus replicated much less efficiently in Vero cells (Fig. 2b) , human epithelial cell line A549 (Fig. 2c) and human extravillous trophoblast placental cells HTR-8 (Fig. 2d) , and did not produce detectable replication in the interferon α/β receptor-deficient mouse embryonic fibroblasts (IFNAR −/− MEFs) ( Supplementary Fig. 2c ). The mosquitospecific 316Q/461G virus also induced lower cytopathicity in Vero cells compared to WT virus, while mammalian-specific viruses 350L and 350L/397S induced higher cytopathicity than WT virus ( Supplementary Fig. 2d ). Despite the consistent growth defect observed for the mosquito-specific 316Q/461G virus in all mammalian cell lines tested, this virus replicated with efficiencies similar to WT virus in C6/36 and Aag2 mosquito cell lines ( Fig. 2e and Supplementary Fig. 2f ). Notably, while combined 316Q/461G substitutions were stable, a single K316Q substitution was not, giving rise to an additional S66L mutation when the virus was grown in either mammalian or mosquito cell lines (see Supplementary Notes). Virus infectivity assays showed that the defect in virus replication for mosquito-specific viruses in mammalian (Vero) cells was not due to a defect in their ability to infect these cells (Supplementary Fig. 3a) . Virus binding assay also failed to show any difference in binding to Vero and C6/36 cells between WT and 316Q/461G viruses ( Supplementary Fig. 3b) . The above observations indicate that these substitutions affect virus assembly/ formation and/or secretion in mammalian cells.
The 316Q/461G virus exhibits a temperature-dependent defect in replication in mammalian cells and decreased thermal stability. Mosquito cells grow at a lower temperature (28 °C) than mammalian cells (37 °C) . The 316Q/461G virus secreted similar levels of infectious virus particles compared with WT virus when grown in Vero cells at 28 °C, whereas at 37 °C the 316Q/461G virus produced far fewer secreted infectious virus particles than WT virus (Fig. 2f) . ZIKV particles were reported as having higher thermal stability than other flaviviruses such as Dengue virus (DENV) 21 . Virus particles produced in C6/36 cells were treated at temperatures ranging from 30 to 45 °C for 5 h, and virus infectivity was determined in Vero cells by iPA. The 316Q/461G virus displayed considerably lower thermal stability compared to the WT virus or the 316Q and 461G viruses (Fig. 2g) .
The 316Q/461G virus is defective in secretion/spread of infectious virus particles in mammalian cells. We next tested whether the reduced levels of secreted infectious virus particles for the 316Q/461G virus at 37 °C was caused by a defect in either the intracellular accumulation or secretion of virion proteins. Immunoprecipitation analysis with anti-E antibodies of 35 S-labelled infected Vero or C6/36 cells showed that secretion (but not intracellular accumulation) of virion proteins was severely inhibited for the 316Q/461G virus in Vero cells but not in C6/36 cells (Fig. 2h) . Quantification of virion proteins by ELISA with anti-E antibodies and of viral RNA by RT-qPCR at 3 days post-infection (dpi) showed considerably fewer virion proteins and less viral RNA in the culture fluid of Vero cells infected with 316Q/461G virus compared with WT virus (Fig. 2i,k) . Although intracellular viral E protein levels were somewhat lower for 316Q/461G than for WT virus infection in Vero cells (Fig. 2j) , intracellular viral RNA levels were not significantly different between the two viruses (Fig. 2l) . Immunofluorescence analysis of infected Vero and C6/36 cells with anti-E antibody showed that the E protein of 316Q/461G virus was retained in perinuclear regions in Vero cells, but not in C6/36 cells (Fig. 3a) . In contrast, WT viral E protein was evenly distributed and extended beyond the perinuclear region in both cell lines (Fig. 3a) . Immunostaining of infected cells incubated in liquid media (as opposed to semi-solid media used for standard titrations by iPA) after infection further confirmed a defect in the release/spread of 316Q/461G virus in Vero, but not in C6/36 cells ( Supplementary Fig. 3c,d ).
Transmission electron microscopy (TEM) of infected cells demonstrates a defect in virion formation for the 316Q/461G virus in mammalian cells. To further identify steps in the assembly/ formation and/or secretion of virions potentially affected by the 316Q/461 G substitutions, TEM of infected cells was performed. Compared to C6/36 infections, visibly fewer virions were seen in Vero cells infected with 316Q/461G virus than with WT virus (Fig. 3b) , despite the presence of clear markers of infection in the form of induced convoluting membrane structures ( Supplementary  Fig. 4a 
Articles
Nature Microbiology
Molecular analysis and modelling of S461G and K316Q substitutions. In the heterodimeric mature ZIKV structure, the S461 residue in the E protein is in contact with M protein (Fig. 4a) . Protein contact analysis by Molecular Operating Environment (MOE) software with default contact threshold settings (Supplementary Table 3) identified contacts of S461 with six residues in M (highlighted in pink in Fig. 4b ). The S461G substitution eliminated three of these contacts ( Fig. 4c and Supplementary Table 4) , one of which is the E24 residue of M previously reported to make polar contact with S461 (ref. 22 ). Free energy calculations of overall E-M interaction in the heterodimer revealed that of all possible substitutions, G provides the largest change in free energy (Supplementary Table 5 ) and thus causes the lowest interaction strength between E and M.
Modelling of ZIKV pr protein (using the low-pH DENV heterodimeric structure) revealed a potential salt bridge between D57 of pr and K316 of E (Fig. 4d, enlarged bottom right) . We also noted a complementary interface between the negatively charged underside of pr and the positively charged region (containing were subjected to heat treatment at the indicated temperatures for 5 h and then titred. All culture supernatants above were harvested at their indicated timepoints after infection, and virus titres determined by iPA in Vero cells; n = 3 independent experiments for all assays, and statistical analysis was performed by two-way analysis of variance with Tukey's multiple comparisons test against WT virus. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001. Mean ± s.e.m. Limit of detection for iPA is 1.6 log 10 FFU ml -1 . h, Immunoprecipitation with anti-E antibody (6B6C-1) of 35 S-labelled cell lysates (C) or supernatants (S) from Vero or C6/36 cells infected with WT or 316Q/461 G mutant viruses. E protein indicated by the arrowhead. i,j, Antigen-capture enzyme-linked immunosorbent assay (ELISA) detection of extracellular (i) and intracellular (j) E protein. Dotted lines show the limit of detection, n = 3 independent experiments. k,l, Detection of extracellular (k) and intracellular (l) viral RNA by RT-qPCR. ND, not detected. Mean ± s.e.m., n = 3 independent experiments. Statistical analysis for RT-qPCR data was performed using unpaired t-test, two-tailed. ***P = 0.0005.
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Nature Microbiology K316) surrounding the fusion loop on the E dimer ( Supplementary  Fig. 5a ). Patch analysis showed that the K316 residue is key in the formation of a positive patch on E ( Supplementary Fig. 5b ). The K316Q substitution would remove any potential salt bridge and/ or the positive patch ( Supplementary Fig. 5b ), which would lead to reduced interaction between pr and E. The S66L mutation that developed in the Q316 virus may compensate by providing increased pr-E interaction via a potential hydrophobic interaction with A47 of pr (Fig. 4d , bottom left with L replacing the WT S residue).
The 316Q/461G virus replicates inefficiently and causes less disruption to the development of human brain organoids. We next assessed the ability of the WT and 316Q/461G viruses to infect and replicate in induced pluripotent stem cell (iPSC)-derived human brain organoids. The 316Q/461G virus replicated less efficiently than WT virus (Fig. 5a ) and did not induce severe growth retardation of brain organoids when compared with WT virus infection (Fig. 5b,c) . In organoids, 4 and 18 days post-infection (dpi), detection of virus with antibodies against the ZIKV E protein revealed abundant WT virus in positive neuronal progenitor cells expressing SOX2 (Fig. 5d) and BRN2 (Fig. 5e ), consistent with previous reports 23, 24 . The prevalence of 316Q/461G virus in these progenitor cells was found to be much lower (Fig. 5d ,e), as expected from the lower viral titres (Fig. 5a ). The 316Q/461G virus-infected organoids, in most respects, developed similarly to the mock-infected organoids-both showed a clearly delineated outer layer of MAP2-expressing neurons ( Fig. 5f ) whereas WT virus-infected organoids displayed cortical disorganization at 18 dpi (Fig. 5f ). Previous reports indicated that ZIKV virus infection leads to premature differentiation, reduced proliferation and increased cell death in organoids 25, 26 . In agreement with these data, we observed an early increase in TBR1-expressing cells (Fig. 5g) , a decreased number of cells expressing the proliferation marker Ki67 (Fig. 5h ) and an increased number of cells expressing the apoptosis marker activated caspase 3 ( Fig. 5i) in WT virus-infected organoids. These changes were not observed in organoids infected with the 316Q/461G virus, which exhibited TBR1, Ki67 and activated caspase 3 staining comparable to mock-infected organoids (Fig. 5g,h,i ). Viral RNA replication and changes in expression of marker genes were independently confirmed by RT-qPCR from organoids collected at 18 dpi (Supplementary Fig. 6 ). strain ZIKV E dimer (PDB accession no. 5IZ7) showing the position of the S461G mutation (red spheres) in the mature structure. E and M proteins are represented by green and yellow ribbon structures, respectively. b, Residue S461 sits in a pocket in contact with six M protein residues: Y74, S75 (from chain D in M protein) and S8, K11, E24 and H28 (from chain F in M protein). Contact atoms are surrounded by pink highlights. Protein contact analysis was performed using MOE software package (using 5IZ7). c, The S461G substitution resulted in only three residues in contact with G461. The S461G mutation was introduced on the 5IZ7 structure followed by energy minimization and protein contact analysis by MOE. d, Homology model of ZIKV-Natal pr protein (based on DENV structure PDB:3C5X and generated using Swiss-Model) fitted to the cryo-EM structure for low-pH immature DENV (EMD-5006), showing a potential salt bridge forming between D57 in pr and K316 in E-DIII (right inset). A S66L mutation can potentially result in hydrophobic interaction between L66 in E-DII and A47 in pr (left inset). 
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The 316Q/461G virus is highly attenuated in IFNAR −/− mice but induces complete protection against a lethal challenge. IFNAR1 −/− C57BL/6 mice were infected with 10 4 focus-forming units (FFU) per mouse of the 316Q/461G or WT virus by subcutaneous injection, and viraemia was assessed daily until 7 dpi (Fig. 6a) . Infection with WT virus produced a viraemia, as observed in our previous studies 12, 27 , while no viraemia was detected in 316Q/461G-infected mice (Fig. 6b) . Mouse sera were collected on 21 dpi (Fig. 6a) , with a 50% plaque reduction neutralization test (PRNT 50 ) titre of 1:2,560-1:5,120 detected in WT virus-infected mice, and 1:640-1:1,280 in mice receiving the 316Q/461G virus (Fig. 6c) . At 37 dpi, mice were challenged subcutaneously with a lethal dose (10 3 50% cell culture infectious dose (CCID 50 )) of the African ZIKV-MR766 strain 12 ( Fig. 6a) . ZIKV-MR766 viraemia was detected in the naïve group from days 2-7 post-challenge, while WT and 316Q/461G virusimmunized groups showed no viraemia (Fig. 6d) . Minimal (<5%) to no weight loss was observed in mice from the latter groups (Fig.  6e) , and all mice survived challenge (Fig. 6f) . In the naïve group, significant weight loss was recorded up to 7 days post-challenge (Fig. 6e) and all mice had succumbed to ZIKV-MR766 infection by day 7 post-challenge (Fig. 6f) . The 316Q/461G virus was thus highly effective in eliciting protective immune responses in IFNAR −/− mice. The 316Q/461G virions showed similar structural morphology to WT virus by electron microscopy ( Supplementary Fig. 7a ), and both viruses showed a similar capacity to be neutralized by anti-ZIKV monoclonal antibodies (Supplementary Fig. 7b ). In addition, while ZIKV-specific monoclonal antibodies ( Supplementary  Fig. 7c ) and human serum ( Supplementary Fig. 7d ) were able to enhance infection by WT virus in human K562 cells, such antibodydependent enhancement (ADE) was significantly less apparent for 316Q/461G virus ( Supplementary Fig. 7c,d ). The attenuated replication of 316Q/461G virus in mammalian cells was thus maintained even in ADE settings. Furthermore, both substitutions were stably maintained after five passages in either C6/36 or Vero cells (Supplementary Fig. 7e ). These observations, and the ability to grow the virus to high yields in mosquito cells, support the vaccine potential of the 316Q/461G virus. In addition, lack of replication in IFNAR −/− cells and undetectable viraemia in IFNAR −/− mice illustrate effective virus attenuation even when the innate antiviral response is missing-an important safety feature when considering immunization of immunocompromised and pregnant individuals.
Discussion
Herein we have used DMS methodology and selection in mosquito and mammalian cells to identify two substitutions in the ZIKV E protein, K316Q and S461G, that together strongly favoured virus replication in mosquito cells. A mutant virus, 316Q/461G, containing these substitutions was subsequently found to be highly 
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−/− mice. After exposure to the acidic pH of the trans-Golgi (TGN), the prM-E arrangement on the flavivirus surface transitions from a heterotrimer to a 'flatten' heterodimer [28] [29] [30] . This conformational change was proposed to be caused by the tightening of the unfolded portion of pr (termed 'drawstring'), pulling down the folded head of pr along with the interacting domain II of E, and potentiating/ spring-loading the heterodimer structure 31 . The S461 residue on E forms an interaction with M in the heterodimeric 21 ( Fig. 4a,b) (but not the heterotrimeric) structure and is implicated in the formation and stability of prM-E heterodimers 32, 33 . The reduced number of virus particles (Supplementary Fig. 4b ) and reduced M-E interaction (Fig. 4c) suggests that S461G substitution destabilizes prM-E heterodimers. This may promote virion disassembly during energyintensive structural rearrangements that occur in the transition from heterotrimer to heterodimer.
As a result of the structural rearrangements in the TGN, the furin cleavage site on prM is exposed, allowing cleavage of prM to pr and M. The pr protein remains associated with E (via noncovalent interactions) to prevent exposure of the fusion loop and premature fusion in the low-pH environment of the TGN 34 . Additionally, pr was also proposed to bind to both E monomers on the heterodimeric structure, and to latch them in this springloaded conformation 31 . K316 is positioned below the pr domain in the low-pH structure [35] [36] [37] , and our modelling suggests that it may form a salt bridge (Fig. 4d, bottom right) and/or charge interactions with pr ( Supplementary Fig. 5 ). The K316Q substitution may thus diminish the non-covalent association between pr and E, thereby potentially promoting release of the latch and premature exposure of the fusion loop. Such activity may initiate premature fusion events during virus transit through TGN. The S66L mutation may partially compensate by providing increased pr-E interactions.
In addition, secreted 316Q/461G particles were also much less thermally stable than WT virus particles (Fig. 2g) , consistent with diminished E-M and/or E-pr interactions caused by the 316Q/461G substitutions. Coincidentally, a T267Q mutation in E-DII has recently been reported to render ZIKV thermally unstable, with the disruption of hydrophobic interactions between E and M proposed to be the mechanism 38 . Our results and this observation illustrate the importance of E-M interaction in ensuring the high thermal stability of ZIKV virions.
The mosquito cell-selected 316Q and 461G substitutions identified herein have not been found in any arbovirus from genus flaviviruses sequenced to date. However, these amino acids can be found in insect-specific flaviviruses (Supplementary Notes and  Supplementary Table 2 ). Why these substitutions were selected in C6/36 cells remains unclear. Studies of DENV2 suggest there is a reduced capacity to adopt configurations leading to fusion at lower temperatures 31 . Conceivably, the 316Q and 461G substitutions may have been selected because they reduce the energy hurdles for transition from the smooth structure through to the ultimate infectious fusogenic forms at lower temperatures.
In summary, we describe herein the use of a DMS screen to identify residues in the E protein of ZIKV that confer advantage to virus replication in primate or mosquito cells. The 316Q/461G virus, which incorporates two substitutions selected in mosquito cells, replicated efficiently in mosquito cells at 28 °C but grew poorly in mammalian cells at 37 °C. The 316Q/461G virus also showed potential as an attenuated vaccine, showing no detectable viraemia in IFNAR −/− mice, but provided complete protection against lethal ZIKV challenge (Fig. 6 ). Our findings illustrate the power of DMS in identifying amino acids that are key to regulating virus replication in specific host environments and in the discovery of virus strains with vaccine potential.
Methods
Generation and deep sequencing of DMS DNA amplicon for C-terminal 204 codons of E gene. Codon mutagenesis was performed following the method previously described 39 , stopping at the step of joining PCR. The forward and reverse mutagenesis primers are described in Supplementary Table 1 . The forward mutagenesis primers pool is used in combination with the Natal2_R primer (5' CTTTCACGGGGTGTCCAATTAGCTCTGAAG 3'), while the reverse mutagenesis primers pool is used in combination with the Natal1_F primer (5' AGTTGTTGATCTGTGTGAATCAGAC 3'). The left fragment pool (indicated by the blue lines in Fig. 1a ) ranges from 1,880 to 2,489 base pairs (bp), and the right fragment pool (indicated by the red lines in Fig. 1a ) ranges from 1,367 to 1,979 bp. Successful amplification of these fragments was confirmed by DNA gel electrophoresis, appearing as short smears. The left and right fragment pools were gel purified and then subjected to joining PCR (or anneal and extension PCR). Briefly, 325.5 ng of purified left fragment pool (representing approximately 1.38 × 10 11 copies of double-stranded DNA (dsDNA)) and 242 ng of right fragment pool (representing approximately 1.33 × 10 11 copies of dsDNA) were added to the joining PCR reaction using PrimeSTAR GXL DNA polymerase (Takara Bio). Joining PCR was performed for 30 cycles, using a touchdown programme (annealing temperature set from 66 to 36 °C over 30 cycles), and the fused fragment was purified by gel purification. The DNA amplicon fragment containing the mutagenized region was then PCR amplified using the Natal1_F (5' AGTTGTTGATCTGTGTGAATCAGAC) and Natal2_R (5' CTTTCACGGGGTGTCCAATTAGCTCTGAAG) primers, and including 147 ng of joining PCR fragment (approximately 3.53 × 10 10 copies of dsDNA) as template. The extent of mutagenesis observed in the DNA amplicon fragment was analysed as described in Supplementary Data 1 (see also https://github.com/ jbloomlab/ZIKV_DMS_w_Khromykh). Barcoded subamplicon sequencing was previously described (in ref. 4 , and in the dms_tools2 documentation-https:// jbloomlab.github.io/dms_tools2/bcsubamp.html), except that the DMS region in the ZIKV E-DIII stem-anchor was divided into two barcoded subamplicons labelled E1 and E2 ( Supplementary Fig. 8a) . Briefly, the method is divided into two stages (PCR1 and PCR2, Supplementary Fig. 8b ). In PCR1, E1 and E2 fragments are amplified using the primers E1_F ( 5' C TT TC CC TA CA CG AC GC-TC TT CC GA TC TN NN NN NN Nc gc ct ga aaatggataaacttagattg), E1_R (5' GGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNN tgccactcctgtgccagtg), E2_F ( 5' C TT TC CC TA CA CG AC GC TC TT CC GA TC TN NN NN NN Ng gg gagaagaagatcacccac) and E2_R (5' GGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNNNNcaccgagcaccccacatc). The partial adaptors are indicated in upper case, random barcodes are indicated by the 8 Ns and the gene-specific sequences are indicated by lower-case letters. PCR1 products were then gel purified and diluted to reduce barcode diversity in PCR2 (Supplementary Fig. 8c ). The PCR2 reaction was performed using the primers U ni ve rs al Rn d2for (5' A AT GA TA CG GC GA CC AC CG AG AT CT AC AC TC TT TC-CCTACACGACGCTCTTCC) and index01Rnd2rev (5' C AAGCAGAAGACGGCA TACGAGATacatcgGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT), thus completing the adaptor sequences. Sequencing was performed on Illumina MiSeq v.3 2 × 300 bp.
Computational analysis of deep sequencing data. The deep sequencing data were analysed using v.2.2.dev6 of the software dms_tools2, which is available at http://jbloomlab.github.io/dms_tools2. Supplementary Data 1 contains a hypertext markup language-rendered file, which contains a Jupyter notebook with plots detailing the deep sequencing data analysis as generated using the dms_tools2 software. All code and input data are provided in Supplementary Data 2, including all steps of the analysis beginning with downloading the FASTQ files from the Sequence Read Archive. The actual code in these files is also available on GitHub at https://github.com/jbloomlab/ZIKV_DMS_w_Khromykh. As the paired-end reads for sequencing of the mutated region were separated into two subamplicons ( Supplementary Fig. 8 ), the combined (for example, double or triple) mutations across the entire mutated region could not be determined.
Generation of infectious ZIKV DMS DNA library by CPER and selection in
Vero and C6/36 cells. The above DMS DNA amplicon was then used in equimolar amounts with other ZIKV cDNA fragments and a linker fragment containing either mammalian CMV 12, 16, 17, 19, 20 or insect OpIE2 18 promoters in a CPER reaction, to produce an infectious DNA library as previously described 12 . The CPER-assembled infectious DNA library containing the CMV promoter was then transfected into Vero cells while the CPER-assembled infectious DNA library containing the OpIE2 promoter was transfected into C6/36 cells. Selection of beneficial mutations was carried out by incubating transfected Vero cells for 8 days and transfected C6/36 cells for 13 days. Secreted viruses were collected at these times, viral RNA purified by Trizol LS (Sigma-Aldrich), E1 and E2 barcoded subamplicons generated by RT-PCR (as in Supplementary Fig. 8 penicillin, 50 µg ml -1 streptomycin, 2% carboxymethyl cellulose) was added. Forty-eight hours after infection, the overlay was removed; 100 μl of ice-cold 80% acetone in phosphate buffered saline (PBS) was added and incubated at -20 °C for 1 h to fix the cells, and then air-dried. For antibody probing, the plate was first blocked for 30 min at 37 °C with 50 µl of blocking solution (Pierce Clear Milk Blocking Buffer, Thermo Scientific), followed by the addition of the primary 50 µl of mAb 4G2 (mouse anti-E) for 1 h at 37 °C. Plates were then washed six times with PBS containing 0.05% Tween 20 (PBS/T). Secondary antibody (IRDye 800CW Goat anti-Mouse, LI-COR) was added (25 µl per well) and incubated for 1 h at 37 °C. Plates were washed six times, air-dried and then kept in the dark at room temperature until ready for imaging. Plates were scanned using the LI-COR Biosciences Odyssey Infrared Imaging System with the following specifications: channel = 800, intensity = auto, focal length = 3 mm, resolution = 42 µm. Viral titres from iPA are expressed as FFU ml Briefly, 200 μl of virus inoculum diluted to the required MOI was added to each well of the six-well plates and incubated at 37 °C with 5% CO 2 (mammalian cells), or at 28 °C (mosquito cells) for 1 h, with rocking every 15 min. After infection, the cell monolayers were washed three times with additive-free DMEM/RPMI. Thereafter, 3 ml of media (depending on cell type; see Cell culture, above) was added to each well. At the timepoints indicated in the Figures, a 150 µl culture supernatant sample was harvested and stored at -80 °C. Samples were then titred by iPA as described above.
Antigen-capture ELISA. Nunc MaxiSorp flat-bottom 96-well plates (Nunc) were coated with fusion peptide-specific mAb BJ-6E6 (125 ng per well) at 4 °C overnight in PBS. Culture supernatant or cell lysates harvested in NP40-lysis buffer (Thermo Fisher Scientific, No. FNN0021) were diluted in twofold serial dilutions in blocking buffer (0.05 M Tris-HCl pH 8.0, 1 mM EDTA, 0.15 M NaCl, 0.05% v/v Tween 20, 0.2% w/v casein) and then incubated on the coated plates for 2 h at 37 °C. This was followed by the addition of human anti-E-DIII mAb ZV-67 used at a concentration of 0.31 µg ml -1 in blocking buffer, incubated at room temperature for 1 h and detected with horseradish peroxidase-conjugated rabbit anti-human IgG antibody (Dako) used at 1:3,000 dilution in blocking buffer. Plates were washed twice with PBS/T between all steps. ABTS substrate solution (0.02% (w/v) ABTS, 0.06% (v/v) H 2 O 2 ) was added and wells were read on an ultraviolet plate reader at 405 nm after 1 h (Labsystems Multiscan EX Type 355, Pathtec). The ELISA threshold was set at mean plus twice the standard deviation of mock.
Real-time RT-PCR. RNA purification was performed either using TRI Reagent (Sigma-Aldrich) or from culture supernatant with NucleoSpin RNA Virus (Macherey-Nagel). Purified RNA samples were added with primers specific for ZIKV RNA ( TEM of infected cells. Cell pellets were fixed in 3% glutaraldehyde in PBS for 2 h at room temperature, washed with 0.1 M cacodylate buffer and incubated in 1% OsO 4 (in 0.1 M cacodylate buffer) for 40 min at room temperature. Samples were then washed once with 0.1 M cacodylate and once in 80% acetone for a further incubation overnight at 4 °C in 2% uranyl acetate/80% acetone. The following day, serial dehydration and resin infiltration steps were performed as follows: 2 × 10 min with 80% acetone, 2 × 10 min with 90% acetone, 3 × 20 min with 100% acetone, 1 × 90 min with 50% Epon/50% acetone, 1 × 90 min with 75% Epon/25% acetone
then trimmed using a DiATOME Ultra Diamond Knife on a Leica EM UC7 ultramicrotome, from which 50 nm sections were obtained and mounted on EM copper grids with formvar/carbon coating. Sections were post-stained in 4% uranyl acetate in water and Reynolds' lead citrate for 5 min each and then processed for TEM imaging using either a FEI Tecnai F20 S/TEM electron microscope or Talos L120C TEM.
Heat treatment of virus particles.
To analyse viral thermal sensitivity, approximately 10 6 FFU of each virus was subjected to a thermal gradient treatment from 30 to 45 °C for 5 h with a thermocycler (Bio-Rad T100 Thermal Cycler), after which samples were immediately titred by iPA on Vero cells. Relative infectivity was determined by calculating the ratio of the number of FFU in heattreated versus the respective non-heat-treated viruses (kept at 4 °C for 5 h). Three independent experiments were conducted.
Radio-immunoprecipitation assay. Vero or C6/36 cells were seeded at a cell density of 5 × 10 5 or 1 × 10 6 cells per well of a six-well plate, respectively. The following day, cells were infected at a MOI of 10 (for Vero cells) or a MOI of 1 (for C6/36 cells) with ZIKV-Natal, ZIKV-316Q/461G or uninfected. At 6 dpi, C6/36 cells were incubated in DMEM supplemented with 50 µg ml -1 actinomycin D for 6 h, followed by starvation medium (DMEM, l-methionine-free, l-cysteine-free, Life Technologies) supplemented with 50 µg ml -1 actinomycin D for 30 min to deplete endogenous methionine and cysteine, and then supplemented with 35 S-lmethionine and 35 S-l-cysteine (EasyTa EXPRESS35S Protein Labeling Mix, Perkin Elmer) to a final concentration of 200 microcuries (µCi) ml -1 . Cells were incubated for a further 24 h and supernatant was harvested and clarified by centrifugation, while cell lysates were harvested in 500 µl NP40 lysis buffer (50 mM Tris, pH 7.4, 250 mM NaCl, 5 mM EDTA, 1% Nonide P40) supplemented with cOmplete Protease Inhibitor Cocktail (Sigma-Aldrich) and lysed by passage through a 29 G insulin needle (Becton Dickinson). Vero sampling followed the same procedure, except that ZIKV-Natal-infected cells were treated at 2 dpi while ZIKV-316Q/461G and uninfected cells were treated at 3 dpi. All samples were stored at -80 °C.
Immunoprecipitation was performed using Dynabead Protein A (Life Technologies). Briefly, for each sample 50 µl of Dynabeads Protein A were loaded with 10 µg of purified 6B6C-1 mAb (anti-E) in a 1.5 ml tube by incubation on a rotary mixer at 4 °C. After 2 h, unbound antibodies were removed by washing once with PBS/T, followed by incubation with 1 ml of supernatant samples or 250 µl of cell lysate samples, and allowed to incubate at 4 °C on the rotary mixer for a further 2 h. Dynabeads were washed twice with PBS/T and then proteins were eluted by incubation in 30 µl of NuPAGE LDS Sample Buffer (Life Technologies) at 70 °C for 5 min. Twenty-five microlitres of each sample were then loaded into each lane of a 1.0 mm, 15-well NuPAGE 4-12% Bis-Tris Protein Gel (Life Technologies) and resolved by SDS-PAGE. Proteins were then transferred onto a nitrocellulose membrane using the iBlot 2 Dry Blotting System (Life Technologies) according to the manufacturer's instructions, exposed to a storage phosphor screen (GE Healthcare Life Sciences) for 3 days and then imaged on the Typhoon FLA 7000 (GE Healthcare Life Sciences).
Culture of iPSC-derived human brain organoids. Generation of human iPSC was carried out as previously described 40 , with the following modifications. Cell line Genea022 (ref. 41 Infection of iPSC-derived human brain organoids. Cerebral organoids at day 15 were utilized for viral infection. A virus inoculum titre of 10 4 FFU per 50 μl of ZIKV-Natal or ZIKV-316Q/461G was added to a single organoid-containing well of a round-bottom, ultra-low-attachment 96-well plate and incubated at 37 °C for 24 h. Each ZIKV-infected organoid was then transferred to a single well of a 24-well plate (Corning) containing 500 μl of ND medium.
To determine viral growth kinetics in infected organoids, at the indicated timepoints, 160 μl of culture supernatant was harvested from each well and then replaced by the same amount of fresh culture medium. Harvested culture supernatants were titred by iPA. Three infected organoids per virus were used. Infected organoids were imaged by dark-field microscopy with ×4 magnification using a Nikon Eclipse TE200 inverted microscope, and organoid dimensions were measured using ImageJ.
For immunofluorescence analysis, infected organoids were harvested at 4 and 18 dpi, fixed overnight in 4% paraformaldehyde and maintained in 30% sucrose solution for 48 h before being embedded with optimal cutting temperature compound (OCT; Leica). The CryoStar NX70 Cryostat (Thermo Fisher Scientific) was then used to prepare 10 µm cryosections, which were stained for organoid markers and co-stained with 4G2 mAb (anti-ZIKV E). Antibodiesused against organoid markers were anti-rabbit SOX2 ( Molecular modelling and simulation. The MOE 2016.08 (Chemical Computing Group) was used for molecular computational chemistry. Energy minimization of the K316Q or S461G mutated structure, interaction analysis of the residues, free energy calculations of the single amino acid substitutions and protein surface patch analysis were conducted in the setting of the Amber10:EHT force field and the generalized Born/volume integral implicit solvent model. The default MOE settings were used for other detailed parameters.
ADE assay. Twenty-five microlitres of twofold serially diluted mAbs or serum were incubated with an equal volume of virus at 37 °C for 1 h, at a MOI of 3. K562 cells adjusted to a concentration of 5 × 10 4 cells 50 μl -1 in serum-free RPMI 1640 medium were added to the mAb-virus mixture in a 1.5 ml microcentrifuge tube and incubated at 37 °C for 2 h with gentle tapping every 15 min. Cells were then washed twice with 1 ml of serum-free RPMI 1640 to remove unbound virus and mAb. Cells were incubated in RPMI 1640 containing 2% FCS. Culture supernatants were harvested at 48 h post-infection, clarified and viral titres quantified by iPA on Vero cells. Three independent experiments were performed.
Plaque reduction neutralization test. Vero cells were seeded in 96-well plates as according to the iPA procedure described above. Sera from infected IFNAR1 −/− C57BL/6 mice were inactivated at 56 °C for 30 min. Twofold serial dilutions of serum samples (from 1:5 to 1:10,240 in DMEM containing 4% FCS, 50 units ml -1 penicillin and 50 µg ml -1 streptomycin) or mAb 4G2, ZV-67 and C8 were incubated with 50-100 FFU of ZIKV-MR766, ZIKV-Natal (WT) or ZIKV-316Q/461G for 20 min at room temperature and then at 37 °C for 1 h. Subsequently, each mixture (100 ul) was added to a Vero cell monolayer and incubated at 37 °C. After 2 h, the inoculum was removed and overlay medium added. The plates were incubated at 37 °C in a 5% CO 2 atmosphere for 24 h. The cells were fixed and probed as described above for iPA, with the exception that PRNT plates of mouse serum samples were probed using human mAb ZV-67 (anti-E) as primary antibody and IRDye 800CW goat anti-human as secondary antibody. Relative infectivity was determined by tabulating the ratio of number of FFUs in each serum/mAb dilution to the no-antibody control for each virus. Viral cytotoxicity assay. Vero cells were seeded into 96-well plates at a density of 2 × 10 4 cells per well. Serial 0.5-log 10 dilutions of viruses with concentration ranging from 2 × 10 6 to 2 FFU ml -1 were prepared, and 100 ul of each dilution were used to infect the cells at 24 h after seeding; eight wells of cells were left uninfected (mock), to be used as control. Infection was performed by incubation with the inocula for 24 h, which were then replaced with 100 ul per well DMEM supplemented with 2% FCS. At 5 dpi, cytopathic effects were determined based on cellular adenosine triphosphate levels using Viral ToxGlo Assay (Promega) according to the manufacturer's instructions. Luminescence was measured on a DTX880 Multimode Detector (Beckman Coulter). Percentage survival was determined as the percentage of luciferase activity (luminescence value) in infected cells compared to uninfected control, and cytopathic effect (CPE) was calculated as 100% -(% survival). The experiment was performed in duplicate. Data was fitted into sigmodal curves using GraphPad Prism v7.0.
Immunofluorescence analysis of infected cells. Vero or C6/36 cells were seeded on glass coverslips in a 24-well plate at a density of 1 × 10 4 or 1 × 10 5 cells per well, respectively. Cells were then infected with ZIKV-Natal or ZIKV-316Q/461G at a MOI of 1 and incubated at 37 °C (Vero) or 28 °C (C6/36). After 1 h, cells were washed and replaced with fresh medium and then incubated at 37 °C (Vero) or 28 °C (C6/36). Both ZIKV-Natal-and ZIKV-316Q/461G-infected C6/36 cells were fixed and stained at 5 dpi. ZIKV-Natal-infected Vero cells were fixed and stained at 3 dpi, while ZIKV-316Q/461G-infected Vero cells were fixed at 4 dpi. Fixing and staining procedures were as follows: glass coverslips were removed and submerged in 100% acetone at 20°C for 5 min, and then allowed to air-dry completely. Coverslips were then blocked with 250 µl blocking solution (Pierc Clear Milk Blocking Buffer, Thermo Scientific) for 1 h at room temperature before incubation with 4G2 (anti-E) diluted in PBS/T for a further 1 h. Coverslips were then washed three times with PBS/T and incubated with goat anti-mouse IgG Alexa Fluor 488 secondary antibody (Life Technologies) diluted in PBS/T for a final 1 h. Coverslips were then washed three times with PBS/T and mounted onto microscope glass slides with ProLong Diamond Antifade Mountant with DAPI (Life Technologies). Images were taken using a Zeiss LSM 710 confocal microscope.
Cryo-EM of secreted virus particles. ZIKV-316Q/461G virions were prepared for TEM analysis as described previously 42 . Briefly, virus was precipitated from clarified culture supernatants using PEG 8000, resuspended in NaCl-Tris-EDTA (NTE) buffer (10 mM Tris pH 8, 120 mM NaCl, 1 mM EDTA) before ultracentrifugation through a 20% sucrose cushion and a final purification step on a 10-40% potassium tartrate gradient. The virus band was harvested and buffer exchanged into NTE, and final preparations (4 µl) were applied to freshly glow-discharged 400-mesh holey carbon-coated copper grids (Proscitech). Grids were blotted for 7 s at 100% relative humidity before plunge-freezing in liquid ethane using a Vitrobot (FEI). Cryo-EM images were acquired at 300 kV with an FEI Tecnai F30 G2 microscope, equipped with a K2 summit direct electron detector (Gatan).
Viral infectivity assay.
To assess the infectivity of viral mutants in different cell types, all virus stocks were first titred on iPA using a C6/36 monolayer and normalized to approximately 10 5 FFU ml -1 and separately aliquoted. Virus aliquots were then simultaneously titred on iPA using C6/36 or Vero cell monolayers in the same experiment. Three independent experiments were conducted. Viral spread assay. Vero or C6/36 cells were seeded at a cell density of 5 × 10 5 or 1 × 10 6 cells per well, respectively, of a six-well plate. The following day, cells were infected at a MOI of 0.0001 with ZIKV-Natal or ZIKV-316Q/461G for 1 h, and then washed and incubated in their respective culture media. Plates were fixed and stained, and then imaged at the different timepoints using the same procedures as described for iPA above.
Mouse experiments. Ten-week-old IFNAR1
−/− C57BL/6 male mice were infected via subcutaneous injection with ZIKV-Natal (WT), ZIKV-316Q/461G or were uninfected (naïve group), and viraemia was monitored daily for 7 dpi. At 21 dpi, blood samples were harvested by tail bleed to determine the neutralizing antibody response levels against virulent ZIKV-MR766. At 37 days post-vaccination, mice were challenged with a lethal dose of 10 3 CCID 50 per animal of ZIKV-MR766 and viraemia was determined daily for 7 days post-challenge. Weight loss and mortality rate were measured for up to 21 days post-challenge. 
Data availability
Deep sequencing data are deposited on the Sequence Read Archive under PRJNA449413. Data files are also provided as Supplementary Data 1 and 2. The software suite for DMS data analysis can be found on https://github.com/ jbloomlab/dms_tools2. The actual code used to run the suite in this study is at https://github.com/jbloomlab/ZIKV_DMS_w_Khromykh 1 nature research | reporting summary 
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The statistical test(s) used AND whether they are one-or two-sided
Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
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Data collection
Data collection was performed by illumina deep sequencing, no custom software was used.
Data analysis
The custom script dms_tools2 (version 2.2.dev6) was used for data analysis, available at http://jbloomlab.github.io/dms_tools2
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Deep sequencing data are deposited on the Sequence Read Archive under PRJNA449413, which contains the raw data that is processed by dms_tools2 software as detailed in Supplementary Data 1 and Supplementary Data 2. Generated figures appear in Figure 1 and Figure S1 .
